Marian Vincenzi
Overview
Explore the profile of Marian Vincenzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vincenzi M, Mercurio F, Autiero I, Leone M
Molecules
. 2025 Feb;
30(3).
PMID: 39942820
Recently, SASH1 has emerged as a novel protein interactor of a few Eph tyrosine kinase receptors like EphA2. These interactions involve the first N-terminal Sam (sterile alpha motif) domain of...
2.
Cugudda A, La Manna S, Leone M, Vincenzi M, Marasco D
Eur J Med Chem
. 2024 Nov;
282:117107.
PMID: 39608205
Peptidomimetics of Suppressors of cytokine signaling 1 (SOCS1) protein demonstrated valid therapeutic potentials as anti-inflammatory agents. Indeed, SOCS1 has a small kinase inhibitory region (KIR) primarily involved in the inhibition...
3.
Vincenzi M, Mercurio F, La Manna S, Palumbo R, Pirone L, Marasco D, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408946
The Sam (Sterile alpha motif) domain of the lipid phosphatase Ship2 (Ship2-Sam) is engaged by the Sam domain of the receptor tyrosine kinase EphA2 (EphA2-Sam) and, this interaction is principally...
4.
Vincenzi M, Mercurio F, Palumbo R, La Manna S, Pirone L, Marasco D, et al.
J Med Chem
. 2024 Sep;
67(18):16649-16663.
PMID: 39259672
The Sam (sterile alpha motif) domain from the lipid phosphatase Ship2 binds the Sam domain from the EphA2 receptor to negatively regulate receptor endocytosis and degradation. This interaction is primarily...
5.
Vincenzi M, Mercurio F, Autiero I, Leone M
Molecules
. 2024 Mar;
29(5).
PMID: 38474536
The lipid phosphatase Ship2 interacts with the EphA2 receptor by forming a heterotypic Sam (sterile alpha motif)-Sam complex. Ship2 works as a negative regulator of receptor endocytosis and consequent degradation,...
6.
Vincenzi M, Mercurio F, Leone M
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38339078
Over the last few decades, we have witnessed growing interest from both academic and industrial laboratories in peptides as possible therapeutics. Bioactive peptides have a high potential to treat various...
7.
Vincenzi M, Mercurio F, Leone M
Curr Med Chem
. 2023 Oct;
31(35):5670-5701.
PMID: 37828671
Background: The receptor tyrosine kinase EphA2 plays a role in many diseases, like cancer, cataracts, and osteoporosis. Interestingly, it has also been linked to viral infections. Objective: Herein, current literature...
8.
Vincenzi M, Mercurio F, Leone M
Curr Med Chem
. 2022 Oct;
30(28):3158-3214.
PMID: 36200217
Background: In the last few years, in silico tools, including drug repurposing coupled with structure-based virtual screening, have been extensively employed to look for anti-COVID-19 agents. Objective: The present review...
9.
Mercurio F, Vincenzi M, Leone M
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142306
Among the diverse protein binding modules, Sam (Sterile alpha motif) domains attract attention due to their versatility. They are present in different organisms and play many functions in physiological and...
10.
Vincenzi M, Mercurio F, Di Natale C, Palumbo R, Pirone L, La Manna S, et al.
Bioorg Chem
. 2022 Mar;
122:105680.
PMID: 35248981
The lipid phosphatase Ship2 binds the EphA2 receptor through a heterotypic Sam-Sam (Sterile alpha motif) interaction. Inhibitors of the Ship2-Sam/EphA2-Sam complex hold a certain potential as novel anticancer agents. The...